Literature DB >> 14675739

Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse.

Jun Ren1, James E Porter, Loren E Wold, Nicholas S Aberle, Dhanasekaran Muralikrishnan, James R Haselton.   

Abstract

Radiotracer and biochemical studies have shown that patients with Parkinson disease lack functional sympathetic innervation to the heart. The same observation was made in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), an experimental model of Parkinson disease. This study examined the mechanical properties, adrenergic receptor level and intracellular Ca2+ handling in cardiac myocytes isolated from C57/BL6 mice that received either MPTP (30 mg/kg, i.p., twice in 24 h) or vehicle. Mechanical properties were evaluated using an IonOptix MyoCam system. Myocytes were electrically stimulated at 0.5 Hz. The contractile properties analyzed included peak shortening (PS), time-to-PS (TPS), time-to-90% relengthening (TR90), and maximal velocities of shortening and relengthen (+/-dL/dt). Intracellular Ca2+ handling was evaluated with fura 2. Myocytes from MPTP-treated mice exhibited a depressed PS (85% of normal), normal TPS, prolonged TR90 (147% of normal), and reduced +/-dL/dt (both 79% of normal). These results were correlated with a 67% reduction of beta-adrenergic receptor expression in myocardial membranes from MPTP-treated mice when compared to normal. Myocytes from MPTP-treated mice also exhibited a reduced peak of intracellular Ca2+ sequestration and sarcoplasmic reticulum (SR) Ca2+ load (55 and 38% of normal, respectively). The resting intracellular Ca2+ and Ca2+-transient decay were comparable to the values seen in myocytes from untreated mice. Myocytes from MPTP-treated and untreated mice were equally responsive over a range of stimulation frequencies (0.1, 0.5, 1, 3 and 5 z). Response to norepinephrine (1 microM) and isoproterenol (1 microM) was reduced in myocytes from MPTP-treated mice. These results demonstrate substantial cardiac dysfunctions in this model of experimental Parkinson disease, probably due to reduced adrenergic responsiveness and SR Ca2+ load.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675739     DOI: 10.1016/s0197-4580(03)00035-6

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  Cardiovascular remodeling in response to long-term exposure to fine particulate matter air pollution.

Authors:  Loren E Wold; Zhekang Ying; Kirk R Hutchinson; Markus Velten; Matthew W Gorr; Christina Velten; Dane J Youtz; Aixia Wang; Pamela A Lucchesi; Qinghua Sun; Sanjay Rajagopalan
Journal:  Circ Heart Fail       Date:  2012-06-01       Impact factor: 8.790

2.  The progressive effects of a fat enriched diet on ventricular myocyte contraction and intracellular Ca2+ in the C57BL/6J mouse.

Authors:  F C Howarth; M A Qureshi; A J Gbewonyo; S Tariq; E Adeghate
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

3.  Adverse perinatal environment contributes to altered cardiac development and function.

Authors:  Markus Velten; Matthew W Gorr; Dane J Youtz; Christina Velten; Lynette K Rogers; Loren E Wold
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-03-07       Impact factor: 4.733

Review 4.  Non-motor features of Parkinson disease.

Authors:  Anthony H V Schapira; K Ray Chaudhuri; Peter Jenner
Journal:  Nat Rev Neurosci       Date:  2017-06-08       Impact factor: 34.870

5.  Threonine-5 at the N-terminus can modulate sarcolipin function in cardiac myocytes.

Authors:  Poornima Bhupathy; Gopal J Babu; Makoto Ito; Muthu Periasamy
Journal:  J Mol Cell Cardiol       Date:  2009-07-23       Impact factor: 5.000

6.  Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: An Immunohistochemistry Study.

Authors:  Nour S Erekat; Muhammed D Al-Jarrah
Journal:  Med Sci Monit Basic Res       Date:  2018-08-23

7.  Cardiac and Autonomic Dysfunctions Assessed Through Recurrence Quantitative Analysis of Electrocardiogram Signals and an Application to the 6-Hydroxydopamine Parkinson's Disease Animal Model.

Authors:  Lucas Shinoda; Laís Damasceno; Leandro Freitas; Ruy Campos; Sergio Cravo; Carla A Scorza; Fúlvio A Scorza; Jean Faber
Journal:  Front Physiol       Date:  2021-11-24       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.